The Translational Genomics Group established by Professor Matthew Brown is based at QUT’s Institute for Health and Biomedical Innovation (IHBI) at the Translational Research Institute in Brisbane, Queensland. The team of academics, health care professionals and research higher degree students work in diverse areas of chronic disease and cancer research, tackling the pressing need to understand the complexity of human disease for the development of future treatments.

The Australian Translational Genomic Centre (ATGC) operates within the group and is a partnership between QUT and Metro South to provide tumour sequencing and mutational profiling for cancer patients across Queensland. The centre is the first of its kind in the state and will provide clinicians treating cancer patients with advanced genetic information addressing the underlying causes of tumour development, predicted outcomes and personalised treatment avenues.

The group also researches and publishes extensively on a range of diseases, including ankylosing spondylitis, rheumatoid arthritis, type 1 diabetes, cervical and lung cancer and scleroderma, continuing to contribute substantially to the understanding of disease genetics and functional biology.